Navigation Links
Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna
Date:10/13/2010

Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna -- OOSTERHOUT, Netherlands, Oct. 13 /PRNewswire-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Trade Show News Click to view news release full screen  

Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna

   

Two-Day Multiplexing Symposium Brings Together Leading Scientists to Discuss New Developments in Clinical Diagnostics and Life Science Research


Download image

OOSTERHOUT, Netherlands, Oct. 13 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX), today announced that it will host Planet xMAP Europe 2010, its annual European multiplexing technology symposium, October 20-21, 2010, at The Hofburg in Vienna, Austria. The event will feature scientific sessions, workshops, discussion groups, exhibitions and networking events with scientists and researchers from around the world who are performing groundbreaking work in clinical diagnostics and life science research using Luminex's xMAP® multiplexing technology platform.

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100104/LUMINEXLOGO)

"Planet xMAP Europe is an excellent opportunity for scientists to gather and exchange ideas on how xMAP multiplexing technology is revolutionizing their laboratories and research," said Paul C. Ladestein, General Manager European Operations for Luminex. "We look forward to welcoming these leading scientists to our exciting new venue at The Hofburg in Vienna."

Planet xMAP Europe 2010 will feature two days of presentations with six focused session options.

Day One of Planet xMAP Europe 2010, Wednesday, 20 October, will focus on Pathogen Detection, Immunology-Monitoring and HLA-Human Genetics. The morning session will include the following presentations:

- Professor Sabine Bahn, MD, PhD, MRCPsych, of the Cambridge Centre for Neuropsychiatric Research Institute of Biotechnology, University of Cambridge, UK, "Disease Biomarkers in First-onset Schizophrenia"

- Professor Jean Louis Merlin, PharmD, PhD, of Tumor Biology Unit, Nancy University Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France, "Phosphoprotein array for characterization of Human Tyrosine kinase receptors downstream signaling functionality as response predictive marker to targeted therapy in translational oncology research programs"

- Professor Alex van Belkum, Department of Medical Microbiology and Infectious Diseases Erasmus MC, Rotterdam, The Netherlands, "Multi-parameter assessment of the humoral response to colonisation and infection with opportunistic microbial pathogens from the human Nasopharyngeal cavity"

- Professor Jonas Blomberg, Section of Virology, Department of Medical Sciences, Uppsala University, Sweden, "More for less; multiplex broadly targeted nucleic acid and serology analyses from the same clinical sample"

- Tim Dehne, Vice President of Systems Research and Development, Luminex Corporation, "MAGPIX: The Next Dimension in Multiplexing"

The afternoon session will feature three separate tracks focused on Pathogen Detection, Immunology-Monitoring, and Human Genetics.

Day Two of Planet xMAP Europe 2010, Thursday, 21 October, will focus on Protein and Genomic Research, and xTAG RVP Fast.The morning session will include the following presentations:

- Carlo M. Croce, MD, Department of Molecular Virology, Immunology and Medical Genetics The Ohio State University Medical Center, Columbus, Ohio, USA, "Causes and consequences of microRNA Dysregulation in cancer"

- Nicholas Haining, Assistant Professor of Pediatrics, Department of Pediatric Oncology Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA, "Gene-expression based high-throughput screening"

- Anna E. Lokshin, PhD, Hillman Cancer Institute, Luminex Core Facility, University of Pittsburgh, USA, "Urine as a source of cancer biomarkers"

The afternoon session will feature a special xTAG RVP Fast Workshop on current and future trends in respiratory viral testing.

For detailed information regarding the Planet xMAP Europe 2010 symposium and agenda, or to register online, please visit http://www.planetxmap.com.

About Luminex CorporationLuminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's xMAP® multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics markets. The Company's xMAP technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP can be obtained at www.luminexcorp.com.Luminex Corporate Contact:Harriss T. CurrieVice President, Finance and Chief Financial Officer512.219.8020Matthew ScaloSr. Director Investor Relations512.219.8020mscalo@luminexcorp.comLuminex Media Contact:Aaron De Lucia512-241-2249aaron.delucia@porternovelli.com
'/>"/>

SOURCE Luminex Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution
2. Luminex Corporation Wins Prestigious 2010 Prix Galien USA Award
3. Luminex to Host MAGPIX Road Shows Throughout the U.S. and Europe
4. Luminex Corporation to Present at UBS Global Life Sciences Conference
5. Luminex MAGPIX System Shown to be More Cost Effective and Efficient Than Conventional ELISA Method in Initial Study
6. Luminex Announces Commercial Launch of New Cystic Fibrosis Test
7. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
8. Arable Corporation Announces New Technology for Clinical Trial Industry
9. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
10. Medical Simulation Corporation Signs Agreement With a Nationally Ranked Hospital
11. United American Healthcare Corporation Announces Results of Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Feb. 12, 2016  Apellis Pharmaceuticals, ... a $47.1 million Series D preferred stock ... Management, Hillhouse Capital Group and venBio Global ... Investments, AJU IB Investment, and Epidarex Capital. The ... to further advance clinical trials in the ...
(Date:2/11/2016)... 2016 Stem cells are primitive cells found ... and the capacity to differentiate into mature cell types ... the first mouse embryonic stem cells were derived from ... that the first culturing of embryonic stem cells from ... produced until 2006 As a result of these discoveries, ...
(Date:2/11/2016)... 11, 2016  Governor Andrew M. Cuomo today announced ... jobs throughout Western New York . ... SUNY Polytechnic Institute, includes a major expansion of Athenex,s ... Buffalo , as well as the creation ... Dunkirk . The combined projects are ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... Miami Dental Specialists is excited to ... Miami dental office. Beginning in January, Miami Dental Specialists will offer the non-metal implants ... the first office to be chosen by the dental implant manufacturer, Straumann, to bring ...
(Date:2/12/2016)... ... February 12, 2016 , ... Nearly every health website and ... These articles generally list between five and 15 foods that should be consumed ... one of these lists and believes that nutritious eye healthy foods are extremely ...
(Date:2/12/2016)... , ... February 12, 2016 , ... A lot has ... 35 years. A president has access to health and wellness resources most Americans could ... world, no single individual has a schedule as frenetic as the U.S. President. ...
(Date:2/12/2016)... ... 12, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... he says are the real facts surrounding all those Bible stories. For generations families ... school teachers, and Yisrayl says there is more to these than just mere “stories”. ...
(Date:2/12/2016)... ... 2016 , ... Dignity Health named Dr. Scott Bingham the Facility Medical Director ... facility is licensed under Dignity Health Arizona General Hospital , which opened last ... will ensure our new freestanding emergency room delivers the highest quality care to Mesa ...
Breaking Medicine News(10 mins):